The new variant of Salmonella genomic island 1 (SGI1-V) from a proteus mirabilis French clinical isolate harbours bla VEB-6 and qnrA1 in the multiple antibiotic resistance region

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 11, 2011, Pages 2513-2520

  Siebor, Eliane ^a   Neuwirth, Catherine ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

ESBLs; Fluoroquinolone resistance; Genomic island SGI1; Multidrug resistance; P. mirabilis

Indexed keywords

AMINOGLYCOSIDE; CEFOXITIN; COTRIMOXAZOLE; FOSFOMYCIN; IMIPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIOPHAGE; BACTERIUM ISOLATE; DNA SEQUENCE; GENE CASSETTE; GENE DELETION; GENE DOSAGE; GENE INSERTION; GENE LOCATION; GENE REARRANGEMENT; GENETIC VARIABILITY; GENOMIC ISLAND; INTEGRON; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEUS MIRABILIS; SALMONELLA; STRUCTURAL HOMOLOGY; THDF GENE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; GENOMIC ISLANDS; HUMANS; INTEGRONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEUS INFECTIONS; PROTEUS MIRABILIS; SALMONELLA; SEQUENCE ANALYSIS, DNA;

EID: 80054686720     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr335     Document Type: Article

References (43)

1. Zong Z, Partridge SR, Iredell JR. A blaVEB-1 variant, blaVEB-6, associated with repeated elements in a complex genetic structure. Antimicrob Agents Chemother 2009; 53: 1693-7.
2. Naas T, Poirel L, Karim A et al. Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiol Lett 1999; 176: 411-9.
3. Poirel L, Menuteau O, Agoli N et al. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003; 41: 3542-7.
4. Neuwirth C, Freby C, Ogier-Desserrey A et al. VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France. Emerg Infect Dis 2006; 12: 1737-9.
5. Poirel L, Naas T, Guibert M et al. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrob Agents Chemother 1999; 43: 573-81.
6. Girlich D, Poirel L, Leelaporn A et al. Molecular epidemiology of the integron-located VEB-1 extended-spectrum β-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol 2001; 39: 175-82.
7. Cao V, Lambert T, Nhu DQ et al. Distribution of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother 2002; 46: 3739-43.
8. Aubert D, Naas T, Lartigue MF et al. Novel genetic structure associated with an extended-spectrum β-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria. Antimicrob Agents Chemother 2005; 49: 3590-2.
9. Naas T, Benaoudia F, Massuard S et al. Integron-located VEB-1 extended-spectrum β-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam. J Antimicrob Chemother 2000; 46: 703-11.
10. Aragón LM, Mirelis B, Miró E et al. Increase in β-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type β-lactamases. J Antimicrob Chemother 2008; 61: 1029-32.
11. Naas T, Mikami Y, Imai T et al. Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes. J Bacteriol 2001; 183: 235-49.
12. Aubert D, Girlich D, Naas T et al. Functional and structural characterization of the genetic environment of an extended-spectrum β-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob Agents Chemother 2004; 48: 3284-90.
13. Naas T, Aubert D, Lambert T et al. Complex genetic structures with repeated elements, a sul-type class 1 integron, and the blaVEB extended-spectrum β-lactamase gene. Antimicrob Agents Chemother 2006; 50: 1745-52.
14. Poirel L, Mugnier PD, Toleman MA et al. ISCR2, another vehicle for blaVEB gene acquisition. Antimicrob Agents Chemother 2009; 53: 4940-3.
15. Fournier PE, Vallenet D, Barbe V et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006; 2: e7.
16. Boyd D, Peters GA, Cloeckaert A et al. Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. J Bacteriol 2001; 183: 5725-32.
17. Boyd D, Cloeckaert A, Chaslus-Dancla E et al. Characterization of variant Salmonella genomic island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob Agents Chemother 2002; 46: 1714-22.
18. Mulvey MR, Boyd DA, Olson AB et al. The genetics of Salmonella genomic island 1. Microbes Infect 2006; 8: 1915-22.
19. Doublet B, Boyd D, Mulvey MR et al. The Salmonella genomic island 1 is an integrative mobilizable element. Mol Microbiol 2005; 55: 1911-24.
20. Doublet B, Golding GR, Mulvey MR et al. Potential integration sites of the Salmonella genomic island 1 in Proteus mirabilis and other bacteria. J Antimicrob Chemother 2007; 59: 801-3.
21. Ahmed AM, Hussein AI, Shimamoto T. Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region. J Antimicrob Chemother 2007; 59: 184-90.
22. Boyd DA, Shi X, Hu QH et al. Salmonella genomic island 1 (SGI1), variant SGI1-I, and new variant SGI1-O in Proteus mirabilis clinical and food isolates from China. Antimicrob Agents Chemother 2008; 52: 340-4.
23. Bi S, Yan H, Chen M et al. New variant Salmonella genomic island 1-U in Proteus mirabilis clinical and food isolates from South China. J Antimicrob Chemother 2011; 66: 1178-9.
24. Doublet B, Poirel L, Praud K et al. European clinical isolate of Proteus mirabilis harbouring the Salmonella genomic island 1 variant SGI1-O. J Antimicrob Chemother 2010; 65: 2260-2.
25. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
26. Jarlier V, Nicolas MH, Fournier G et al. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-78.
27. Barthelemy M, Guionie M, Labia R. β-lactamases: determination of their isoelectric points. Antimicrob Agents Chemother 1978; 13: 695-8.
28. Pilhofer M, Bauer AP, Schrallhammer M et al. Characterization of bacterial operons consisting of two tubulins and a kinesin-like gene by the novel Two-Step Gene Walking method. Nucleic Acids Res 2007; 35: e135.
29. Lukashin AV, Borodovsky M. GeneMark.hmm: new solutions for gene finding. Nucleic Acids Res 1998; 26: 1107-15.
30. Partridge SR, Recchia GD, Stokes HW et al. Family of class 1 integrons related to In4 from Tn1696. Antimicrob Agents Chemother 2001; 45: 3014-20.
31. Stokes HW, O'Gorman DB, Recchia GD et al. Structure and function of 59-base element recombination sites associated with mobile gene cassettes. Mol Microbiol 1997; 26: 731-45.
32. Partridge SR, Tsafnat G, Coiera E et al. Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol Rev 2009; 33: 757-84.
33. Rowe-Magnus DA, Guérout AM, Mazel D. Super-integrons. Res Microbiol 1999; 150: 641-51.
34. Burrus V, Marrero J, Waldor MK. The current ICE age: biology and evolution of SXT-related integrating conjugative elements. Plasmid 2006; 55: 173-83.
35. Doublet B, Praud K, Bertrand S et al. Novel insertion sequence- and transposon-mediated genetic rearrangements in genomic island SGI1 of Salmonella enterica serovar Kentucky. Antimicrob Agents Chemother 2008; 52: 3745-54.
36. Doublet B, Weill FX, Fabre L et al. Variant Salmonella genomic island 1 antibiotic resistance gene cluster containing a novel 3'-N-aminoglycoside acetyltransferase gene cassette, aac(3)-Id, in Salmonella enterica serovar Newport. Antimicrob Agents Chemother 2004; 48: 3806-12.
37. Vo ATT, van Duijkeren E, Fluit AC et al. A novel Salmonella genomic island 1 and rare types in Salmonella Typhimurium isolates from horses in the Netherlands. J Antimicrob Chemother 2007; 59: 594-9.
38. Shen P, Jiang Y, Zhou Z et al. Complete nucleotide sequence of pKP96, a 67850 bp multiresistance plasmid encoding qnrA1, aac(6')-Ib-cr and blaCTX-M-24 from Klebsiella pneumoniae. J Antimicrob Chemother 2008; 62: 1252-6.
39. Poirel L, Rodriguez-Martinez JM, Mammeri H et al. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother 2005; 49: 3523-5.
40. Standiford HC, Drusano GL, Bustamante CI et al. Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers. Antimicrob Agents Chemother 1986; 29: 412-7.
41. Neuwirth C, Siebor E, Duez JM et al. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins. J Antimicrob Chemother 1995; 36: 335-42.
42. Rasmussen MA, Carlson SA, Franklin SK et al. Exposure to rumen protozoa leads to enhancement of pathogenicity of and invasion by multiple-antibiotic-resistant Salmonella enterica bearing SGI1. Infect Immun 2005; 73: 4668-75.
43. Carlson SA, Sharma VK, McCuddin ZP et al. Involvement of a Salmonella genomic island 1 gene in the rumen protozoanmediated enhancement of invasion for multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium. Infect Immun 2007; 75: 792-800.